期刊文献+

PI3K通路与乳腺癌的关系及其意义的研究进展 被引量:2

原文传递
导出
摘要 磷酸肌醇3-激酶(PI3K)通路与乳腺癌病理生理之间的密切关系已逐渐被阐明,PI3K有望成为靶向治疗的新型靶点。笔者就近年PI3K通路的活性异常与乳腺癌细胞发生发展、转移、耐药的关系以及其作为治疗靶点的应用价值的研究进展作一综述。
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2011年第11期1240-1243,共4页 China Journal of General Surgery
  • 相关文献

参考文献32

  • 1O'Reilly KE, Rojo F, She QB, et al. mTOR inhibition in- duces upstream receptor tyrosine kinase signaling and activates Akt[J~. Cancer Res, 2006, 66(3) :1500- 1508.
  • 2Xu Z, Stokoe D, Kane LP, et al. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells[ J]. Cell Growth Differ, 2002, 13 (7) : 285 -296.
  • 3Bachman KE, Argani P, Samuels Y, et al. The PIK3 CA gene is mutated with high frequency in human breast cancers [ J ]. Cancer Biol Ther, 2004, 3 (8) :772 - 775.
  • 4Hennessy BT, Smith DL, Ram PT, et al. Exploiting the PI3 K/AKT pathway for cancer drug discovery [ J ] . Nat Rev Drug Discov, 2005 , 4(12) :988 - 1004.
  • 5Carpten JD, Faber AL, Horn C, et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [J]. Nature, 2007, 448(7152) :439 -444.
  • 6Stcmke-Hale K, Gonzalez-Angulo AM, Lluch A, et al. An integrative genomic and proteomic analysis of PIK3 CA, PTEN, and AKT mutations in breast cancer [ J ]. Cancer Res, 2008, 68(15):6084-6091.
  • 7Kalinsky K, Jacks LM, Heguy A, et al. PlK3 CA mutation associates with improved outcome in breast cancer [ J ]. Clin Cancer Res, 2009, 15(16) :5049 -5059.
  • 8Keely PJ, Westwick JK, Whitehead IP, et al. Cdc42 and Rac 1 induce integrin-mediated cell motility and invasiveness through PI(3)K[JI. Nature, 1997, 390(6660) :632 -636.
  • 9Pang H, Flinn R, Patsialou A, et al. Differential enhance- ment of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase [ J ]. Cancer Res, 2009, 69 (23) : 8868 - 8876.
  • 10Gonzalez - Angulo AM, Ferrer- Lozano J, Stemke - Hale K, et al. PI3 K pathway mutations and P'I~N levels in primary and metastatic breast cancer[ J ]. Mol Cancer Ther, 2011 , 10 (6) :1093 - 1101.

同被引文献40

  • 1Yang Z, Klionsky DJ. Eaten alive: a history of macroantophagy[J]. Nat Cell Biol, 2010, 12(9):814-822.
  • 2Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of Beclinl, a candidate tumor suppressor gene on chromosome 17q21[J]. Genomics, 1999, 59(1):59-65.
  • 3Li Z, Chen B, Wu Y, et al. Genetic and epigenetic silencing of the Beclinl gene in sporadic breast tumors[J]. BMC Cancers 2010, 10:98.
  • 4Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclinl-dependent autophagy [J]. Cell, 2005, 122(6):927- 939.
  • 5Tooze SA, Yoshimori T. The origin of the autophagosomal membrane [J]. Nat Cell Biol, 2010, 12(9):831-835.
  • 6Kung CP, Budina A, Balaburski G, et al. Autophagy in tumor suppression and cancer therapy [J]. Crit Rev Eukaryot Gene Expr, 2011, 21(1):71-100.
  • 7Morselli E, Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy[J]. Biochim Biophys Acta, 2009, 1793(9): 1524-1532.
  • 8Brech A, Ahlquist T, Lothe RA, et al. Autophagy in tumor suppression and promotion [J]. Mol Oncol, 2009, 3(4):366-375.
  • 9Jin S. p53, Autophagy and tumor suppression[J]. Autophagy, 2005, 1(3):171-173.
  • 10Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis[J]. Cancer Cell, 2006, 10(1):51-64.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部